serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.415 Fatty Alcohols .
D02.033.415.510 Hexanols .
D02.033.415.510.500 Cyclohexanols .
D02.033.415.510.500.303 Desvenlafaxine Succinate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.392 Hydrocarbons, Alicyclic .
D02.455.426.392.368 Cycloparaffins .
D02.455.426.392.368.367 Cyclohexanes .
D02.455.426.392.368.367.318 Cyclohexanols .
D02.455.426.392.368.367.318.500 Desvenlafaxine Succinate .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.265 Desvenlafaxine Succinate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.308 Imidazoles .
D03.383.129.308.436 Imidazolines .
D03.383.129.308.436.750 Tolazoline .
D03.383.725 Pyridines .
D03.383.725.762 Pyridinium Compounds .
D03.383.725.762.232 Cetylpyridinium .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.810 Quinolines .
D03.633.100.810.050 Aminoquinolines .
D03.633.100.810.050.650 Primaquine .
D04 Polycyclic Compounds .
D04.345 Macrocyclic Compounds .
D04.345.566 Peptides, Cyclic .
D04.345.566.802 Streptogramins .
D04.345.566.802.374 Pristinamycin .
D10 Lipids .
D10.289 Fatty Alcohols .
D10.289.510 Hexanols .
D10.289.510.500 Cyclohexanols .
D10.289.510.500.303 Desvenlafaxine Succinate .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.641 Peptides, Cyclic .
D12.644.641.802 Streptogramins .
D12.644.641.802.374 Pristinamycin .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.225 Clinical Laboratory Techniques .
E01.370.225.500 Cytological Techniques .
E01.370.225.500.620 Histocytological Preparation Techniques .
E01.370.225.500.620.670 Staining and Labeling .
E01.370.225.500.620.670.325 In Situ Hybridization .
E01.370.225.500.620.670.325.680 Primed In Situ Labeling .
E01.370.225.750 Histological Techniques .
E01.370.225.750.600 Histocytological Preparation Techniques .
E01.370.225.750.600.670 Staining and Labeling .
E01.370.225.750.600.670.325 In Situ Hybridization .
E01.370.225.750.600.670.325.680 Primed In Situ Labeling .
E05 Investigative Techniques .
E05.200 Clinical Laboratory Techniques .
E05.200.500 Cytological Techniques .
E05.200.500.620 Histocytological Preparation Techniques .
E05.200.500.620.670 Staining and Labeling .
E05.200.500.620.670.325 In Situ Hybridization .
E05.200.500.620.670.325.680 Primed In Situ Labeling .
E05.200.750 Histological Techniques .
E05.200.750.600 Histocytological Preparation Techniques .
E05.200.750.600.670 Staining and Labeling .
E05.200.750.600.670.325 In Situ Hybridization .
E05.200.750.600.670.325.680 Primed In Situ Labeling .
E05.393 Genetic Techniques .
E05.393.620 Nucleic Acid Amplification Techniques .
E05.393.620.500 Polymerase Chain Reaction .
E05.393.620.500.650 Primed In Situ Labeling .
E05.393.661 Nucleic Acid Hybridization .
E05.393.661.475 In Situ Hybridization .
E05.393.661.475.680 Primed In Situ Labeling .
I01 Social Sciences .
I01.880 Sociology .
I01.880.604 Social Control, Formal .
I01.880.604.787 Prisons .
J03 Non-Medical Public and Private Facilities .
J03.693 Prisons .
M01 Persons .
M01.729 Prisoners .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.151 Costs and Cost Analysis .
SP4 Environmental Health .
SP4.051 General Aspects .
SP4.051.497 Costs and Cost Analysis .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.981 Disaster Vulnerability .
SP8.473.981.797 Complex Emergencies .
SP8.473.981.797.832 Prisoners .
VS3 Health Surveillance of Health Services .
VS3.002 Health Facilities .
VS3.002.010 Residential Facilities .
VS3.002.010.012 Prisons .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Cetylpyridinium .
Angifonil .
Biosept .
Catamium .
Ceepryn Chloride .
Cetamium .
Cetylpyridinium Chloride .
Cetylpyridinium Chloride Anhydrous .
Cetylpyridium .
Cetylyre .
Dobendan .
Hexadecylpyridinium .
Merocets .
Pristacin .
Pyrisept .
Sterogenol .
Anhydrous, Cetylpyridinium Chloride .
Chloride Anhydrous, Cetylpyridinium .
Chloride, Ceepryn .
Chloride, Cetylpyridinium .
Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges. .
1.00
43859
 
Desvenlafaxine Succinate .
2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate .
4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol .
Desvenlafaxine .
O-desmethylvenlafaxine .
O-desmethylvenlafaxine Succinate .
O-desmethylvenlafaxine Succinate Monohydrate .
Pristiq .
WY 45,233 .
WY 45233 .
WY-45,233 .
WY-45233 .
45,233, WY .
45233, WY .
Monohydrate, O-desmethylvenlafaxine Succinate .
O desmethylvenlafaxine .
O desmethylvenlafaxine Succinate .
O desmethylvenlafaxine Succinate Monohydrate .
Succinate Monohydrate, O-desmethylvenlafaxine .
Succinate, Desvenlafaxine .
Succinate, O-desmethylvenlafaxine .
WY45,233 .
WY45233 .
A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT. .
0.63
1248
 
Primaquine .
Primacin .
Primaquine Diphosphate .
Primaquine Phosphate .
Diphosphate, Primaquine .
Phosphate, Primaquine .
An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) .
0.62
591602
 
Prisons .
Prison .
Social Adaptation Centers .
Penal Centers .
Jails .
Penal Institutions .
Reformatories .
Penal institutions, or places of confinement for prisoners. .
0.62
4218064
 
Costs and Cost Analysis .
Analysis, Cost .
Cost 2626 .
Cost Analysis .
Cost Comparison .
Cost Measures .
Cost-Minimization Analysis .
Costs and Cost Analyses .
Costs, Cost Analysis .
Pricing .
Analyses, Cost .
Analyses, Cost-Minimization .
Analysis, Cost-Minimization .
Comparison, Cost .
Comparisons, Cost .
Cost Analyses .
Cost Comparisons .
Cost Measure .
Cost Minimization Analysis .
Cost, Cost Analysis .
Cost-Minimization Analyses .
Costs .
Measure, Cost .
Measures, Cost .
Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. .
0.60
87744759
 
Pristinamycin .
Pyostacine .
RP 7293 .
RP7293 .
An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC. .
0.58
2101
 
Tolazoline .
Divascol .
Pridazole .
Priscol .
Priscoline .
Tolazoline Hydrochloride .
Tolazoline Monohydrochloride .
Benzalolin .
A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. .
0.57
7836
 
Prisoners .
Hostage .
Prisoner .
Detainee .
Detainees .
Political Prisoner .
Political Prisoners .
Hostages .
0.56
29913920
 
Primed In Situ Labeling .
Direct In Situ Copy PCR .
DISC-PCR .
In Situ Labeling, Primed .
PRINS .
A technique that labels specific sequences in whole chromosomes by in situ DNA chain elongation or PCR (polymerase chain reaction). .
0.55
2162